Anuncio
Anuncio
KZR
Kezar Life Sciences, Inc. Common Stock
6.22
USDPatrocinado
-0.28
-4.31%
09 ene, 15:58 UTC -5
Cerrado
Post-mercado
6.22
0.00
0.00%
Informes de beneficios de KZR
Ratio de Sorpresa Positivo
KZR superó 23 de las últimas 30 estimaciones.
77%
Próximo informe
Fecha del próximo informe
23 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.31
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/-14.38%
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/-52.71%
Kezar Life Sciences, Inc. Common Stock earnings per share and revenue
On 12 nov 2025, KZR reported earnings of -1.53 USD per share (EPS) for Q3 25, beating the estimate of -2.09 USD, resulting in a 27.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -1.31 USD, with revenue projected to reach -- USD, implying an reducir of -14.38% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
What were Kezar Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Kezar Life Sciences, Inc. Common Stock reported EPS of -$1.53, beating estimates by 27.09%, and revenue of $0.00, 0% as expectations.
How did the market react to Kezar Life Sciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.16%, changed from $6.16 before the earnings release to $6.15 the day after.
When is Kezar Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 mar 2026.
What are the forecasts for Kezar Life Sciences, Inc. Common Stock's next earnings report?
Based on 6
analistas, Kezar Life Sciences, Inc. Common Stock is expected to report EPS of -$1.31 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio